Medical research

Developing a better, faster diagnostic for cryptosporidiosis

Cryptosporidiosis is the leading cause of waterborne diseases among humans in the United States, infecting almost 750,000 people each year, according to the Centers for Disease Control and Prevention. Globally in 2010, nearly ...

Immunology

Fever alters immune cells so they can better reach infections

Fever is known to help power up our immune cells, and scientists in Shanghai have new evidence explaining how. They found in mice that fever alters surface proteins on immune cells like lymphocytes to make them better able ...

Medical research

MANF identified as a rejuvenating factor in parabiosis

Older mice who are surgically joined with young mice in order to share a common bloodstream get stronger and healthier, making parabiosis one of the hottest topics in age research. Publishing in Nature Metabolism, researchers ...

Diseases, Conditions, Syndromes

How to train the body's own cells to combat antibiotic resistance

Drug-resistant superbugs have threatened human health for decades. The situation is getting worse because of the shortage of new antibiotics. But what if we changed the way we aim to treat them, and trained our cells to kill ...

Immunology

Engineered T cells promote long-term organ transplant acceptance

Organ transplant rejection is a major problem in transplantation medicine. Suppressing the immune system to prevent organ rejection, however, opens the door to life-threatening infections. Researchers at the University of ...

Immunology

A molecular switch for stopping inflammation

A component has been identified by researchers in UmeƄ as a novel regulator of the immune system. It acts as a molecular switch to deactivate the innate immune system and has the ability to prevent certain diseases caused ...

Cancer

Drug hobbles deadly liver cancer by stifling protein production

In laboratory experiments, UC San Francisco researchers successfully beat back the growth of aggressive liver cancers using a surprising new approach. Traditionally, targeted cancer therapies aim to disable proteins borne ...

page 2 from 23